1154759-69-9

Basic information

• Product Name: (1-oxa-spiro[2.3]hex-5-yl)-carbamic acid tert-butyl ester
• Synonyms: (1-oxa-spiro[2.3]hex-5-yl)-carbamic acid tert-butyl ester
• CAS NO: 1154759-69-9
• Molecular Weight: 199.25
• Mol File: 1154759-69-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (1-oxa-spiro[2.3]hex-5-yl)-carbamic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (1-oxa-spiro[2.3]hex-5-yl)-carbamic acid tert-butyl ester(1154759-69-9)
• EPA Substance Registry System: (1-oxa-spiro[2.3]hex-5-yl)-carbamic acid tert-butyl ester(1154759-69-9)

Safety Data

• Hazardous Substances Data: 1154759-69-9(Hazardous Substances Data)

Upstream product

• 15760-35-7 3-methylenecyclobutanecarbonitrile 

Downstream Products

• 1427329-27-8 (3-hydroxy-3-methyl-cyclobutyl)-carbamic acid tert-butyl ester 

Relevant articles and documents

1,3 DI-SUBSTITUTED CYCLOBUTANE OR AZETIDINE DERIVATIVES AS HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE INHIBITORS

A compound of formula (I), wherein R, R1, R2, R3, Y, Y1, a, X, and Z are as defined herein. The compounds of the present invention are inhibitors of hematopoietic prostaglandin D synthase (H-PGDS) and can be useful in the treatment of Duchenne Muscular Dystrophy. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting H-PGDS activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.